alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN

Term ID

CHEBI:147460

Synonyms

(2S,3S,4R,5S,6S)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-methyloxane-3,4,5-triol
6-deoxy-alpha-L-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-2-amino-2-deoxy-D-gluco-hexopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-amino-2-deoxy-D-glucopyranose
alpha-L-fucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-amino-2-deoxy-D-glucopyranose
Fuc(a1-3)Gal(b1-4)GlcN

Definition

An amino trisaccharide consisting of α-L-fucopyranosyl, β-D-galactopyranosyl and 2-amino-2-deoxy-D-glucopyranose residues joined in sequence by (1→3) and (1→4) glycosidic bonds.

References

glygen:G13747QM
glytoucan:G13747QM
kegg.glycan:G09174

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN

Phenotype where environments contain alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN

Phenotype modified by environments containing alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN

Phenotype affecting alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-D-GlcpN

Human Disease Model